Seven Eight Capital’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-66,801
| Closed | -$983K | – | 598 |
|
|
2023
Q4 | $983K | Buy |
66,801
+6,910
| +12% | +$102K | 0.11% | 256 |
|
|
2023
Q3 | $1.1M | Buy |
+59,891
| New | +$1.1M | 0.13% | 223 |
|
|
2023
Q2 | – | Sell |
-30,053
| Closed | -$882K | – | 485 |
|
|
2023
Q1 | $882K | Buy |
30,053
+15,115
| +101% | +$443K | 0.18% | 153 |
|
|
2022
Q4 | $552K | Buy |
14,938
+2,876
| +24% | +$106K | 0.14% | 211 |
|
|
2022
Q3 | $340K | Buy |
+12,062
| New | +$340K | 0.07% | 351 |
|